Jazz Pharmaceuticals PLC

Q1 2024 13F Holders

CUSIP
00B4Q5ZN4
Type
Equity
Class
COMMON
Num filings
2
Total reported value, excl. options
$126 M
Manager Report Date Value ($000) Shares Option Type